Key Findings:  This survey was of US veterinarians and their perceptions and practice with cannabis use for canine medical treatments, most frequent being pain, anxiety and phobias, and seizures. Most felt comfortable discussing with colleagues, but less than half felt comfortable discussing with patients. Another finding includes that most believe cannabis and CBD offer health and medical benefits and should not remain a Schedule I drug.
Type of Study:  Meta-analysis
Study Sample Size:  2130
Study Result:  Positive
Study Location(s):  United States
Year of Pub:  2019
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified), Pharma CBD
Phytocannabinoid Source:  Cannabis Flower derived
Chemotype:  Chemotype III